A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...

Rising COPD Cases and Aging Population Drive Demand for Nebulizers, Fueling Market Growth The incidences of chronic diseases, such as COPD, are rising at a more staggering rate. By the year 2050, an ...

Inhalers and nebulizers are necessary when managing chronic obstructive pulmonary disease (COPD). Both are designed to deliver medication directly to the lungs, which helps in reducing symptoms, ...

Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...

The global nebulizers market was valued at US$ 1 billion in 2020. It is estimated to expand at a CAGR of 6.6% from 2021 to 2028, reaching approximately US$ 1.7 billion by the end of 2028. The ...

What it is: COPD stands for chronic obstructive pulmonary disease. Also known as emphysema and chronic bronchitis, COPD is a slow progressing lung disease characterized by an obstruction to airflow ...

Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Nebulizers Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. The global ...

More than 16 million Americans have been diagnosed with chronic obstructive pulmonary disease (COPD) — a group of conditions that cause breathing-related problems. In 2017, 923,000 patients went to ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...